The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dryer, R. L.
Right arrow Articles by Covey, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dryer, R. L.
Right arrow Articles by Covey, L. R.
The Journal of Immunology, 2005, 175: 4499-4507.
Copyright © 2005 by The American Association of Immunologists

A Novel NF-{kappa}B-Regulated Site within the Human I{gamma}1 Promoter Requires p300 for Optimal Transcriptional Activity1

Rebecca L. Dryer and Lori R. Covey2

Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854

Transcriptional activation of germline (GL) promoters occurs through binding of NF-{kappa}B to three evolutionarily conserved sites within a CD40 response region in the human and mouse GL I{gamma} and I{epsilon} promoters. Here we identify and characterize a novel NF-{kappa}B binding site ({kappa}B6) within the human GL I{gamma}1 promoter that plays an essential role in basal- and CD40-induced transcription. This site is adjacent to identified CREB/activating transcription factor (ATF) sites, present in the I{gamma}1 but not the I{gamma}3 promoter, which are important for the amplification of transcription. Our data suggest a cohesive protein complex regulating I{gamma}1 promoter activity because disruption of any individual NF-{kappa}B or CREB/ATF site markedly lowers the overall inducible activity of the promoter. In addition, alteration of helical phasing within the promoter indicates spatial orientation of CREB/ATF and NF-{kappa}B, proteins contributes directly to promoter activity. We found that CREB and p50 transactivators, as well as coactivator p300, interact in vivo with the I{gamma}1 promoter in the presence and absence of CD40 signaling in Ramos and primary B cells. However, the level of CREB and p300 binding differs as a consequence of activation in primary B cells. Furthermore, overexpression of p300, and not a mutant lacking acetyltransferase activity, significantly increases I{gamma}1 construct-specific transcription. Together these data support a model whereby CREB and multiple NF-{kappa}B complexes bind to the I{gamma}1 promoter and recruit p300. CD40 signals induce p300-dependent changes that result in optimal I{gamma}1 promoter activity.




This article has been cited by other articles:


Home page
J. Immunol.Home page
F. L. Sinquett, R. L. Dryer, V. Marcelli, A. Batheja, and L. R. Covey
Single Nucleotide Changes in the Human I{gamma}1 and I{gamma}4 Promoters Underlie Different Transcriptional Responses to CD40
J. Immunol., February 15, 2009; 182(4): 2185 - 2193.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. T. Lu, F. L. Sinquett, R. L. Dryer, C. Song, and L. R. Covey
c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient
Blood, December 1, 2006; 108(12): 3769 - 3776.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.